A Phase 1 study of LY4005130 in healthy participants
Completed Phase 1 NCT06690996
Study Description
A study to evaluate the safety, tolerability, and pharmacokinetics of LY4005130 in healthy individuals
Study Details
- Registry ID:
- NCT06690996
- Conditions:
- Healthy
- Phase:
- Phase 1
- Target Enrollment:
- 110 participants
- Start Date:
- Age Range:
- 18–65 years
- Healthy Volunteers:
- No
Study Locations (2 sites)
-
Fortrea CRU, Inc.
Dallas, Texas, United States -
Fortrea Clinical Research Unit
Dallas, Texas, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.